JANICE CARR: Open Payments
NPI 1235302068 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,224 in 58 payments from 25 companies in 2025. Trend: 2023 $1,150 · 2024 $1,386 · 2025 $1,224
Food & beverage: $1,156Education: $68
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 18 | $355 |
| Janssen Biotech, Inc. | 2 | $132 |
| TAIHO ONCOLOGY, INC. | 4 | $89 |
| ABBVIE INC. | 4 | $62 |
| GENZYME CORPORATION | 3 | $60 |
| Incyte Corporation | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| PharmaEssentia USA Corporation | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $36 |
Products named: Enhertu, RYBREVANT, LONSURF, JAKAFI, OJJAARA, Epkinly, BESREMI, KEYTRUDA.
Industry payments across NJ — which companies pay providers there.
